Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. EFFECT Other Notice of Effectiveness
  2. DEFA14A Proxy Proxy Materials
  3. CT ORDER Other Confidential Order
  4. DEFA14A Proxy Proxy Materials
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. FWP Offering Free Writing Prospectus
  7. EFFECT Other Notice of Effectiveness
  8. FWP Offering Free Writing Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. PRER14A Other PRER14A
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. EFFECT Other Notice of Effectiveness
  13. CT ORDER Other Confidential Order
  14. CERT Other Certification
  15. 8-A12B Other Registration of Securities
  16. DRS/A Other Draft Registration Statement
  17. DRSLTR Other Correspondence Related to Draft Registration Statement
  18. DRS/A Other Draft Registration Statement
  19. DRSLTR Other Correspondence Related to Draft Registration Statement
  20. DRS Other Draft Registration Statement

Page 3 of 3 · 60 filings